Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Levrero

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|June 9, 2016
Aiming for cure in HBV and HDV infectionJörg Petersen, Alexander J Thompson, Massimo Levrero
Blood|March 20, 2004
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cellsPaolo Lunghi, Antonio Costanzo, Massimo Levrero, et al.
Current Opinion in Virology|May 20, 2018
Perspectives and limitations for nucleo(t)side analogs in future HBV therapiesMassimo Levrero, Miroslava Subic, Francois Villeret, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis CGiovanni Raimondo, Teresa Pollicino, Massimo Levrero, et al.
Seminars in Liver Disease|June 11, 2013
Molecular mechanisms of HBV-associated hepatocarcinogenesisFrancesca Guerrieri, Laura Belloni, Natalia Pediconi, et al.
Bulletin Du Cancer|September 21, 2020
[Management of immune checkpoint inhibitors-induced liver toxicity in cancer]Fanny Lebossé, Brigitte Bancel, Massimo Levrero, et al.
Antiviral Research|July 10, 2019
Non-invasive biomarkers for chronic hepatitis B virus infection managementCaroline Charre, Massimo Levrero, Fabien Zoulim, et al.
Cancers|July 2, 2021
The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and BeyondVincenzo Alfano, Mirjam B Zeisel, Massimo Levrero, et al.
Thrombosis Research|June 15, 2024
Liver health in hemophilia in the era of gene therapyYesim Dargaud, Massimo Levrero, François Bailly, et al.
Viruses|November 2, 2018
Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular CarcinomaMarie-Laure Plissonnier, Katharina Herzog, Massimo Levrero, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|June 9, 2016
Aiming for cure in HBV and HDV infectionJörg Petersen, Alexander J Thompson, Massimo Levrero
Blood|March 20, 2004
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cellsPaolo Lunghi, Antonio Costanzo, Massimo Levrero, et al.
Current Opinion in Virology|May 20, 2018
Perspectives and limitations for nucleo(t)side analogs in future HBV therapiesMassimo Levrero, Miroslava Subic, Francois Villeret, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis CGiovanni Raimondo, Teresa Pollicino, Massimo Levrero, et al.
Seminars in Liver Disease|June 11, 2013
Molecular mechanisms of HBV-associated hepatocarcinogenesisFrancesca Guerrieri, Laura Belloni, Natalia Pediconi, et al.
Bulletin Du Cancer|September 21, 2020
[Management of immune checkpoint inhibitors-induced liver toxicity in cancer]Fanny Lebossé, Brigitte Bancel, Massimo Levrero, et al.
Antiviral Research|July 10, 2019
Non-invasive biomarkers for chronic hepatitis B virus infection managementCaroline Charre, Massimo Levrero, Fabien Zoulim, et al.
Cancers|July 2, 2021
The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and BeyondVincenzo Alfano, Mirjam B Zeisel, Massimo Levrero, et al.
Thrombosis Research|June 15, 2024
Liver health in hemophilia in the era of gene therapyYesim Dargaud, Massimo Levrero, François Bailly, et al.
Viruses|November 2, 2018
Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular CarcinomaMarie-Laure Plissonnier, Katharina Herzog, Massimo Levrero, et al.
Pageof 14